S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
"Prepare for Five Years of Famine" (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
"Prepare for Five Years of Famine" (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
"Prepare for Five Years of Famine" (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
"Prepare for Five Years of Famine" (Ad)
S&P 500   4,122.47
DOW   32,774.41
QQQ   317.08
Are Medtronic And Intuitive Surgical Poised For Big Growth?
"Prepare for Five Years of Famine" (Ad)
'The Sacrifice Zone': Myanmar bears cost of green energy
Ralph Lauren Is A Retail Stock You Can Buy And Hold
Closing prices for crude oil, gold and other commodities
"Prepare for Five Years of Famine" (Ad)
Learning from failures: How Biden scored win on climate plan
Most electric vehicles won't qualify for federal tax credit
Is Sofi Financial Stock Finally Ready to Pay Off for Investors?
"Prepare for Five Years of Famine" (Ad)
NASDAQ:CGEM

Cullinan Oncology - CGEM Insider Trading & Ownership

$14.05
-0.38 (-2.63%)
(As of 08/9/2022 12:00 AM ET)
Add
Compare
Today's Range
$13.37
$14.37
50-Day Range
$11.20
$15.42
52-Week Range
$7.30
$30.33
Volume
178,560 shs
Average Volume
362,436 shs
Market Capitalization
$629.20 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$52.00

Cullinan Oncology (NASDAQ:CGEM) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
7.50%
Number Of
Insiders Buying
(Last 12 Months)
2
Amount Of
Insider Buying
(Last 12 Months)
$11.33 M
Number Of
Insiders Selling
(Last 12 Months)
8
Amount Of
Insider Selling
(Last 12 Months)
$12.01 M

CGEM Insider Buying and Selling by Quarter

Get CGEM Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cullinan Oncology stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.


Cullinan Oncology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/4/2022Vision Scs F2Major ShareholderSell25,989$14.31$371,902.591,255,963  
8/2/2022Vision Scs F2Major ShareholderSell4,792$14.10$67,567.201,301,081  
7/25/2022Jennifer MichaelsonInsiderSell8,000$14.51$116,080.0053,031  
7/18/2022Corrine SavillInsiderSell5,042$15.06$75,932.52164,573  
7/11/2022Corrine SavillInsiderSell40,000$13.33$533,200.00169,615  
6/23/2022Bioscience I 2017 Ltd F2Major ShareholderSell29,631$13.00$385,203.00537,392  
6/21/2022Bioscience I 2017 Ltd F2Major ShareholderSell22,319$12.77$285,013.63616,976  
6/6/2022Nadim AhmedCEOBuy8,090$12.40$100,316.008,090  
6/1/2022Bvf Partners L P/IlMajor ShareholderBuy751,396$11.00$8,265,356.004,058,854  
5/16/2022Vision Scs F2Major ShareholderSell35,158$11.23$394,824.341,305,873  
5/12/2022Vision Scs F2Major ShareholderSell264,072$9.25$2,442,666.001,460,539  
4/1/2022Bvf Partners L P/IlMajor ShareholderBuy276,000$10.75$2,967,000.00301,671  
10/18/2021Jennifer MichaelsonInsiderSell4,000$21.42$85,680.00  
10/15/2021Jeffrey TrigilioCFOSell8,000$25.00$200,000.00  
10/15/2021Leigh ZawelInsiderSell19,574$25.00$489,350.00  
10/7/2021Leigh ZawelInsiderSell1,079$25.00$26,975.00  
9/20/2021Jennifer MichaelsonInsiderSell4,000$24.51$98,040.00  
9/15/2021Ansbert GadickeDirectorSell888$29.16$25,894.08  
9/15/2021Oncology Impact Fund L.P. UbsMajor ShareholderSell6,425$29.16$187,353.00  
9/13/2021Ansbert GadickeDirectorSell497$29.10$14,462.70248,170  
9/13/2021Oncology Impact Fund L.P. UbsMajor ShareholderSell3,595$29.10$104,614.50248,170  
9/9/2021Ansbert GadickeDirectorSell1,898$29.35$55,706.30  
9/9/2021Oncology Impact Fund L.P. UbsMajor ShareholderSell13,727$29.35$402,887.45248,170  
9/7/2021Ansbert GadickeDirectorSell3,465$29.04$100,623.60255,032  
9/7/2021Leigh ZawelInsiderSell28,118$28.95$814,016.10  
9/7/2021Oncology Impact Fund L.P. UbsMajor ShareholderSell25,067$29.04$727,945.68  
9/3/2021Ansbert GadickeDirectorSell1,760$29.60$52,096.00255,032  
9/3/2021Oncology Impact Fund L.P. UbsMajor ShareholderSell12,731$29.60$376,837.60255,032  
9/1/2021Ansbert GadickeDirectorSell790$29.47$23,281.30259,975  
9/1/2021Oncology Impact Fund L.P. UbsMajor ShareholderSell5,714$29.47$168,391.58259,975  
8/30/2021Ansbert GadickeDirectorSell4,285$29.30$125,550.50264,437  
8/30/2021Oncology Impact Fund L.P. UbsMajor ShareholderSell31,001$29.30$908,329.30  
8/27/2021Ansbert GadickeDirectorSell1,846$29.09$53,700.14264,437  
8/27/2021Oncology Impact Fund L.P. UbsMajor ShareholderSell13,357$29.09$388,555.13  
8/25/2021Ansbert GadickeDirectorSell237$29.09$6,894.33  
8/25/2021Oncology Impact Fund L.P. UbsMajor ShareholderSell1,713$29.09$49,831.17  
8/23/2021Ansbert GadickeDirectorSell7,376$29.11$214,715.36  
8/23/2021Oncology Impact Fund L.P. UbsMajor ShareholderSell53,359$29.11$1,553,280.49273,545  
8/11/2021Ansbert GadickeDirectorSell347$29.05$10,080.35280,921  
8/11/2021Oncology Impact Fund L.P. UbsMajor ShareholderSell2,510$29.05$72,915.50  
8/9/2021Leigh ZawelInsiderSell21,204$26.57$563,390.28  
(Data available from 1/1/2013 forward)












CGEM Insider Trading Activity - Frequently Asked Questions

Who is on Cullinan Oncology's Insider Roster?

The list of insiders at Cullinan Oncology includes Ansbert Gadicke, Bioscience I 2017 Ltd F2, Bvf Partners L P/Il, Corrine Savill, Jeffrey Trigilio, Jennifer Michaelson, Leigh Zawel, Nadim Ahmed, Oncology Impact Fund L.P. Ubs, and Vision Scs F2. Learn more on insiders at CGEM.

What percentage of Cullinan Oncology stock is owned by insiders?

7.50% of Cullinan Oncology stock is owned by insiders. Learn more on CGEM's insider holdings.

Which Cullinan Oncology insiders have been buying company stock?

The following insiders have purchased CGEM shares in the last 24 months: Bvf Partners L P/Il ($11,232,356.00), and Nadim Ahmed ($100,316.00).

How much insider buying is happening at Cullinan Oncology?

Insiders have purchased a total of 1,035,486 CGEM shares in the last 24 months for a total of $11,332,672.00 bought.

Which Cullinan Oncology insiders have been selling company stock?

The following insiders have sold CGEM shares in the last 24 months: Ansbert Gadicke ($683,004.66), Bioscience I 2017 Ltd F2 ($670,216.63), Corrine Savill ($609,132.52), Jeffrey Trigilio ($200,000.00), Jennifer Michaelson ($299,800.00), Leigh Zawel ($1,893,731.38), Oncology Impact Fund L.P. Ubs ($4,940,941.40), and Vision Scs F2 ($3,276,960.13).

How much insider selling is happening at Cullinan Oncology?

Insiders have sold a total of 713,566 Cullinan Oncology shares in the last 24 months for a total of $12,573,786.72 sold.

This page (NASDAQ:CGEM) was last updated on 8/10/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.